Biotechnology and Development ApS: Financial statements 2024
CVR: 33870639
Source: annual report 2024, Danish Business Authority
01/07/2023 – 30/06/2024
Biotechnology and Development ApS (CVR 33870639) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 107,601 and a net result of DKK 66,166 compared with DKK -14,614 the year before. That is an increase of 3,514.4% compared with the year before. Equity in the 2024 report amounted to DKK 106,926. The solvency ratio was 72.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 107,601
- Profit/Loss
- DKK 66,166
- Equity
- DKK 106,926
- Total Assets
- DKK 147,905
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 108 t. | 66 t. | 107 t. | 1 |
| 2023 | - | 3 t. | -15 t. | 41 t. | 1 |
| 2022 | - | 45 t. | 19 t. | 55 t. | 1 |
| 2021 | - | -7 t. | -22 t. | 36 t. | 1 |
| 2020 | - | 79 t. | 47 t. | 58 t. | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout Biotechnology and Development ApS
Biotechnology and Development ApS is a Danish company of the type Anpartsselskab based in Silkeborg, founded in 2011. The company is registered under the industry Engroshandel med andre råvarer og halvfabrikata. The management consists of Karl Erik Molbech. The company is owned by KLMC Holding ApS. The company has 1 employee (2018). In 2026, the company reported a gross profit of DKK 268,463 and a net result of DKK -54,610 compared with DKK -1,709 the year before. Equity in the 2026 report amounted to DKK 50,608.